His main research concerns GPER, Estrogen receptor, Receptor, Estrogen and Internal medicine. His work deals with themes such as Cerebellum, Cancer research and Pharmacology, which intersect with GPER. His research links Cell biology with Estrogen receptor.
The subject of his Receptor research is within the realm of Biochemistry. The various areas that Eric R. Prossnitz examines in his Estrogen study include Gene expression, Neuroscience and Kinase. His Internal medicine research incorporates themes from Endocrinology and Oncology.
His primary areas of study are Receptor, GPER, Internal medicine, Estrogen receptor and Endocrinology. His work carried out in the field of Receptor brings together such families of science as Signal transduction and Cell biology. His Cell biology research integrates issues from Internalization, Chemotaxis and Transfection.
His GPER research focuses on subjects like Cancer research, which are linked to In vivo. The study of Internal medicine is intertwined with the study of Oncology in a number of ways. His study in Estrogen receptor is interdisciplinary in nature, drawing from both Cell signaling and Estrogen.
Eric R. Prossnitz mainly investigates GPER, Internal medicine, Estrogen receptor, Endocrinology and Estrogen. The GPER study combines topics in areas such as NADPH oxidase, G protein-coupled receptor, Bioinformatics, Hormone and Pharmacology. His research in Internal medicine focuses on subjects like Signal transduction, which are connected to Transcription factor and Kinase.
His Estrogen receptor research includes elements of Cancer research, Agonist, Receptor, Inflammation and Insulin resistance. His research investigates the link between Endocrinology and topics such as Downregulation and upregulation that cross with problems in Age dependent, Endothelin system, Endothelin receptor type A, Endothelin receptor and Left ventricular hypertrophy. His Estrogen research is multidisciplinary, incorporating perspectives in Carcinogenesis, Knockout mouse, Raloxifene Hydrochloride and Thromboxane A2.
Internal medicine, GPER, Estrogen receptor, Endocrinology and Estrogen are his primary areas of study. His study in the fields of Cardiac fibrosis, Muscle hypertrophy, Blood pressure and Cancer under the domain of Internal medicine overlaps with other disciplines such as Vascular smooth muscle. Eric R. Prossnitz interconnects Cancer research, Receptor, G protein-coupled receptor, Estrogen receptor beta and Pharmacology in the investigation of issues within GPER.
Eric R. Prossnitz combines subjects such as NOX1, Prostanoid and Thromboxane A2 with his study of Estrogen receptor. His Endocrinology study integrates concerns from other disciplines, such as Agonist, Inflammation and Signal transduction. The concepts of his Estrogen study are interwoven with issues in Nitric oxide synthase, Knockout mouse and Insulin resistance.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A transmembrane intracellular estrogen receptor mediates rapid cell signaling.
Chetana M. Revankar;Daniel F. Cimino;Larry A. Sklar;Jeffrey B. Arterburn.
Virtual and biomolecular screening converge on a selective agonist for GPR30
Cristian G Bologa;Chetana M Revankar;Susan M Young;Bruce S Edwards.
Nature Chemical Biology (2006)
The G-protein-coupled estrogen receptor GPER in health and disease
Eric R. Prossnitz;Matthias Barton.
Nature Reviews Endocrinology (2011)
Estrogen Signaling through the Transmembrane G Protein–Coupled Receptor GPR30
Eric R. Prossnitz;Jeffrey B. Arterburn;Jeffrey B. Arterburn;Harriet O. Smith;Tudor I. Oprea.
Annual Review of Physiology (2008)
In vivo effects of a GPR30 antagonist
Megan K Dennis;Ritwik Burai;Chinnasamy Ramesh;Whitney K Petrie.
Nature Chemical Biology (2009)
Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system
Eugen Brailoiu;Siok L Dun;G Cristina Brailoiu;Keisuke Mizuo.
Journal of Endocrinology (2007)
G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Lidia Albanito;Antonio Madeo;Rosamaria Lappano;Adele Vivacqua.
Cancer Research (2007)
Mechanisms of estrogen signaling and gene expression via GPR30.
Eric R. Prossnitz;Marcello Maggiolini.
Molecular and Cellular Endocrinology (2009)
Regulatory Role of G Protein–Coupled Estrogen Receptor for Vascular Function and Obesity
Elvira Haas;Indranil Bhattacharya;Eugen Brailoiu;Marlen Damjanović.
Circulation Research (2009)
Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues
Georgina G J Hazell;Song T Yao;James A Roper;Eric R Prossnitz.
Journal of Endocrinology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: